跳至主要内容
临床试验/EUCTR2012-004004-36-AT
EUCTR2012-004004-36-AT进行中(未招募)不适用

Pilot Study to define the Feasibility of ex-vivo LPS stimulated Cytokine release for Testing Efficacy of the Addition of Alanyl-Glutamine-Dipeptide to Dialysis Solutions in Peritoneal Dialysis (PD)

Med. Univ. Wien, UK für Kinder und Jugendheilkunde0 个研究点开始时间: 2012年12月3日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • signed informed consent
  • female, male aged > 19
  • chronic kindney failure; stable for 2 month on PD with Physioneal®
  • no peritonitis within 2 month of study start
  • negative pregnancy test for females with childbearing potential
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 4
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 4

排除标准

  • maligne disease treated with chemotherapy or radiation
  • limited efficacy of PD due to anatomical abnormalities or severe intraabdominal
  • clinically significant increased markers of inflammation
  • body weight < 50 kg
  • Patient under Immunsuppressiva

研究者

发起方
Med. Univ. Wien, UK für Kinder und Jugendheilkunde

相似试验

Pilot Study to define the Feasibility of Cytokine... | 临床试验